APOE and lung cancer: Apolipoprotein APOA1 and APOE-carrying EVs are also increased from nonsmall cell lung cancer cell A549 treated with cisplatin, a platinum-based alkylating agent that binds to DNA and inhibits replication of cancer cells (59).